Brinzolamide With Timolol Maleate
Recommended · restricted OphthalmologyRestrictedSecond-line line
Reduction of elevated intraocular pressure in patients with open-angle glaucoma or ocular hypertension not adequately controlled with monotherapy.
2
Submissions
2010–10
On the record
—
ICER range
Cost-min
Cost basis
Access path
- Mar 2010Recommended · restricted
Comparator changed: dorzolamide with timolol (Cosopt) and individual components…
- Mar 2010Recommended · restricted
Comparator changed: dorzolamide with timolol (Cosopt) and individual components…
- PBS listing · Restricted
RecommendedDeferredNot recommended
Cost-effectiveness
Cost-minimisation analysis; no ICER calculated by design
The submission presented a cost minimisation analysis. PSD · 2010
Decision context
PopulationPatients with open-angle glaucoma or ocular hypertension in whom elevated intraocular pressure is not adequately controlled with monotherapy
Submission history
| Decided | Outcome | Comparator | ICER | Evidence |
|---|---|---|---|---|
| Mar 2010 | Recommended · restricted | dorzolamide with timolol (Cosopt) and individual components (brinzolamide and timolol given concomitantly) | — | RCT · IOP |
| Mar 2010 | Recommended · restricted | dorzolamide with timolol (Cosopt) and individual components (brinzolamide and timolol) given concomitantly | — | RCT · IOP |